Home › NDC Lookup › RxCUI directory › RxCUI 2721609

Zongertinib 60 MG Oral Tablet — RxCUI 2721609

RxNorm drug concept · Semantic clinical drug
RxCUI 2721609 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2721609
Official nameZongertinib 60 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zongertinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Hernexeos is a targeted cancer treatment specifically for adults with a type of lung cancer called non-squamous non-small cell lung cancer (NSCLC) that either can't be removed by s...
  • What exactly is Hernexeos being used to treat in my case?
  • Good news — you can take Hernexeos with or without food, whichever is easiest for you. The important thing is to swallow the tablet whole with water. Don't split, crush, or chew it...
  • Can I take this pill with food, or does it need to be on an empty stomach?
📖 Read our full Zongertinib guide →

🕸️ Concept Web — How Zongertinib 60 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zongertinib 60 MG Oral Tablet RxCUI 2721609

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zongertinib 2721604
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hernexeos 2721610
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zongertinib Oral Tablet 2721608
    • Zongertinib Oral Product 2721606
    • Zongertinib Pill 2721607
    • Zongertinib Oral Tablet [Hernexeos] 2721614
    • Hernexeos Oral Product 2721612
    • Hernexeos Pill 2721613
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zongertinib 60 MG SCDC · 2721605
  • Zongertinib Oral Tablet SCDF · 2721608
  • Zongertinib Oral Product SCDG · 2721606
  • Zongertinib Pill SCDG · 2721607

Brand-Name Concepts

  • Zongertinib 60 MG Oral Tablet [Hernexeos] SBD · 2721615
  • Zongertinib 60 MG [Hernexeos] SBDC · 2721611
  • Zongertinib Oral Tablet [Hernexeos] SBDF · 2721614
  • Hernexeos Oral Product SBDG · 2721612
  • Hernexeos Pill SBDG · 2721613
  • Hernexeos BN · 2721610

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2721609 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-9257-59 1 BOTTLE, PLASTIC in 1 CARTON (0597-9257-59) / 30 TABLET, F... HERNEXEOS Boehringer Ingelheim Pharmaceuticals, Inc. 2026-01-06
00597-9257-86 1 BOTTLE, PLASTIC in 1 CARTON (0597-9257-86) / 60 TABLET, F... HERNEXEOS Boehringer Ingelheim Pharmaceuticals, Inc. 2025-08-08
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.